U.S. market Closed. Opens in 1 hour 37 minutes

POAI | Predictive Oncology Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue1.78M1.51M1.42M1.25M1.41M1.41M654.84K456.50K654.35K951.56K468.12K188.77K96.64K288.0015.74KN/A
Cost of Revenue634.80K505.11K487.02K447.19K531.81K415.76K148.04K181.62K303.98K385.32K189.71K128.54K56.08K140.007.00KN/A
Gross Profit1.15M1.00M933.66K805.08K879.75K995.89K506.79K274.88K350.37K566.24K278.42K60.23K40.56K148.008.74KN/A
Operating Expenses15.13M16.27M14.41M13.29M14.65M8.86M8.25M6.80M4.75M7.03M9.21M7.22M4.15M1.21M2.45M1.67M
Selling, General & Admin10.94M12.47M11.71M10.94M11.69M7.00M8.25M5.64M4.75M7.03M9.21M7.22M4.15M2.07M2.01M1.35M
Research & Development188.31K320.32K315.85K2.35M2.96M1.86M289.00K406.00K261.00K394.00K235.05K15.00KN/AN/AN/AN/A
Other Operating ExpensesN/A3.80M2.70M-1.58M-2.47M68.48KN/A1.16MN/AN/AN/AN/AN/A-868.29K447.00KN/A
Operating Income-13.92M-15.27M-13.47M-666.27K-13.77M-7.86M-7.75M-6.53M-4.40M-6.47M-8.93M-7.16M-4.11M-1.21M-2.44M-1.67M
Other Expenses / Income-62.64K-10.47M-6.85M-13.40M-5.62M-2.23M50.51K-3.00-390.89K-366.12K-619.51K-262.46K-381.49K-147.09K-448.58K-89.34K
Before Tax Income-13.98M-25.74M-20.32M-25.88M-19.39M-10.09M-7.75M-6.53M-4.79M-6.83M-9.41M-7.42M-4.49M-1.35M-1.76MN/A
Income Tax ExpensesN/A10.47M-661.66K11.82M8.17M-2.23M50.50KN/AN/A377.72K636.50K259.35K230.37KN/A448.58K89.34K
Net Income-13.98M-36.21M-19.66M-37.70M-27.56M-10.09M-7.75M-6.53M-4.79M-6.83M-9.41M-7.42M-4.49M-1.35M-2.89M-1.76M
Interest ExpensesN/A10.65MN/AN/AN/AN/AN/A3.00390.89K377.72K636.50K259.35K230.37K147.09K78.94K89.34K
Basic Shares Outstanding4.01M3.65M2.74M597.51K143.51K64.08K31.81K14.12K1.04K618.00586.00277.0085.0037.0030.0027.00
Diluted Shares Outstanding4.01M3.65M2.74M597.51K143.51K64.08K31.81K14.12K1.04K618.00586.00277.0085.0037.0030.0027.00
EBITDA-13.18M-13.95M-12.13M-11.46M-12.41M-7.71M-5.98M-6.44M-4.32M-6.39M-8.76M-7.16M-4.25M-1.20M-2.81M-1.67M
EBITDA Margin-740.52%-926.94%-853.91%-915.03%-879.38%-546.43%-913.51%-1,411.55%-660.36%-671.82%-1,871.64%-3,793.85%-4,401.35%-417,773.26%-17,857.60%0.00%
EBIT-13.98M-15.09M-20.32M-25.88M-19.39M-12.31M-7.70M-6.53M-4.40M-6.08M-8.13M-6.90M-4.03M-1.21M-2.36M-1.58M
EBIT Margin-785.58%-1,002.18%-1,430.22%-2,066.99%-1,373.71%-872.14%-1,175.27%-1,429.59%-672.36%-638.75%-1,737.42%-3,657.03%-4,166.24%-418,616.67%-15,026.45%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙